Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-044658

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John McGrath
Officer — Chief Financial Officer
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 6:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 15, 2015M24,305$0.00A36,705D
Common StockF1May 15, 2015M41,052$0.00A77,757D
Common StockMay 15, 2015F30,405$37.30D47,352D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F2,F3,F4—May 15, 2015A24,305A——Common Stock24,30520,566I
Restricted Stock UnitsF5,F2,F6,F7—May 15, 2015A41,052A——Common Stock41,05282,106I

Explanation of responses